28 March 2024 - Indication includes children ages 6 years and older and weighing at least 30 kg. ...
29 November 2023 - Vertex Pharmaceuticals today announced that Health Canada has granted market authorisation for the expanded use of ...
17 October 2023 - Approximately 330 children with cystic fibrosis ages 2-5 years are now eligible for a medicine that ...
22 April 2023 - Health Canada has approved a new antibody drug to help protect babies from serious illness caused ...
10 April 2023 - With this approval, approximately 30 children with two copies of the F508del mutation are eligible for ...
3 April 2023 - First and only therapy approved to treat this rare and debilitating genetic condition. ...
17 February 2023 - The recommendation is based on clinical data for Moderna's bivalent Omicron targeting COVID-19 vaccine, mRNA.1273.214. ...
8 February 2023 - Adtralza is the first treatment for adolescents with moderate to severe atopic dermatitis specifically targeting the ...
18 January 2023 - Nirsevimab is the first investigational long-acting antibody designed for all infants to help protect against respiratory syncytial ...
9 December 2022 - Today, Health Canada authorised the Pfizer-BioNTech Comirnaty Omicron BA.4/BA.5 bivalent adapted booster for use in children 5 ...
7 December 2022 - Novavax today announced that Health Canada has approved a supplement to a new drug submission for Nuvaxovid ...
9 September 2022 - Health Canada approves Pfizer-BioNTech COVID-19 vaccine for kids under 5. ...
19 August 2022 - The 10 mcg dose can be given at least 6 months after primary series is completed. ...
14 July 2022 - Today, Health Canada authorised the use of the Moderna Spikevax COVID-19 vaccine in children 6 months to ...
22 June 2022 - This approval is supported by 98.4 per cent cure rate across this group of patients who ...